Development of a Novel Nonradioisotopic Assay and Cdc25B Overexpression Cell Lines for Use in Screening for Cdc25B Inhibitors.

Published in: Yonsei medical journal (2018)

The nonradioisotopic Cdk1 kinase assay and Cdc25B overexpression cell lines developed in this study can be conveniently used as tools for screening inhibitors of Cdc25B phosphatase as anticancer drugs.

Keyphrases

cell cycle
cell proliferation
high throughput
protein kinase
tyrosine kinase
drug induced